Pirenzepine exhibits anti-prostate cancer activity and enhances checkpoint inhibitor-based immunotherapy by targeting STING

Jun Xu(Second Affiliated Hospital of Guangzhou Medical University), Yongsheng Yu(Second Affiliated Hospital of Guangzhou Medical University)

European journal of medical research

December 23, 2025

10.1186/s40001-025-03520-4

Cited by 0

Related Papers

H5N1 Virus Hemagglutinin Inhibition of cAMP-Dependent CFTR via TLR4-Mediated Janus Tyrosine Kinase 3 Activation Exacerbates Lung Inflammation

|Molecular Medicine|2015|19